Cargando…
Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
Medullary thyroid cancers (MTCs) are neuroendocrine tumors, which secrete calcitonin and carcinoembryonic antigen, both of which can serve as tumor markers. Extensive and accurate surgical resection is the primary treatment for MTC, whereas the use of external beam radiotherapy is limited. Moreover,...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708888/ https://www.ncbi.nlm.nih.gov/pubmed/31686907 http://dx.doi.org/10.2147/CMAR.S127848 |